Oriental Aromatics Q2 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹1,655 Cr
- P/E
- 159.62
- ROE
- 0.50%
- PEG
- -3.56
- Price to sales
- 1.49
- Debt to equity
- 0.66
- 52W high / low
- ₹630 / ₹235
- Sales growth (5Y)
- 7.78%
- EBITDA margin
- 6.99%
- Net profit margin
- 0.32%
- Promoter holding
- 74.17%
- Sales (last year)
- ₹1,112 Cr
Incorporated in 1973, Oriental Aromatics Ltd is a manufacturer of specialty-based aroma chemicals, camphor, and flavour and fragrance products[1]
Guidance scorecard · Q2 FY27 call
What Oriental Aromatics's management guided
and where it ranks in Chemicals & Petrochemicals
Chemicals & Petrochemicals
RevenueQ2 FY27 call
10–20%- The company targets a steady sales growth CAGR of 10% to 12% over the next 3-4 years.
- Improvement in operational efficiencies and plant utilization, especially at Mahad, is expected to drive volume growth.
- Strategic partnerships, like the one with Unilever, are anticipated to contribute positively to future revenue.
- Continued strength in FMCG and personal care sectors is expected to support fragrance division growth.
- Focus on sustainable and profitable growth across divisions, including expanding fragrance order pipelines domestically and internationally.
- The company plans to maintain a 1/3rd:1/3rd:1/3rd sales ratio among its product segments, supporting balanced growth.
2 more points from Oriental Aromatics's call on revenue
Create a free account to keep reading this call
MarginsQ2 FY27 call
FlatSee what Oriental Aromatics said on margins — free account, 30 seconds.
CapexQ2 FY27 call
Planned- Currently, Oriental Aromatics Limited is in a consolidation phase with no substantial CAPEX in the last one and a half years.
- The company is evaluating multiple options and products for future expansion.
- There are plans to inform the investor community about upcoming CAPEX in the coming quarters.
- The infrastructure at the Mahad facility has been designed to accommodate additional molecules and future phases of expansion.
2 more points from Oriental Aromatics's call on capex
Create a free account to keep reading this call
FundraisingQ2 FY27 call
See what Oriental Aromatics said on fundraising — free account, 30 seconds.
Order bookQ2 FY27 call
Rising- The company is seeing encouraging growth in its fragrance division with steady order flow.
- There is ongoing progress in converting customer qualifications and commercial opportunities into actual sales, especially in the Mahad facility.
- Conversations with existing and new customers indicate scaling up of allocations in RFQs.
2 more points from Oriental Aromatics's call on the order book
Create a free account to keep reading this call
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Chemicals & Petrochemicals companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹1,878 Cr | 21.0 | |
| 2 | 40%+ | Up 0–2% | ₹243 Cr | 3.1 | |
| 3 | 40%+ | Flat | ₹7,887 Cr | 195.1 | |
| 4 | 40%+ | Flat | ₹3,292 Cr | 4.3 | |
| 5 | 40%+ | Flat | ₹2,311 Cr | 26.4 | |
| 6 | 40%+ | Flat | ₹180 Cr | 11.8 |
Sign up free to see every company in the sector ranking and track Oriental Aromatics.
Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals rankingFinancials of Oriental Aromatics
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Shareholder Pattern
Oriental Aromatics
Shareholding breakup across reporting periods.
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters + | 74.17% | 74.17% | 74.17% | 74.17% | 74.17% | 74.17% | 74.17% | 74.17% | 74.17% | 74.17% | 74.17% | 74.17% |
| FIIs + | 0.10% | 0.10% | 0.10% | 0.05% | 0.08% | 0.07% | 0.02% | 0.03% | 0.03% | 0.00% | 0.02% | 0.00% |
| DIIs + | 0.39% | 0.39% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public + | 25.34% | 25.33% | 25.72% | 25.78% | 25.76% | 25.76% | 25.82% | 25.81% | 25.79% | 25.83% | 25.81% | 25.83% |
| No. of Shareholders | 26,545 | 25,875 | 25,715 | 25,898 | 27,213 | 27,118 | 26,258 | 25,734 | 25,032 | 24,382 | 23,728 | 22,148 |
Financials of Oriental Aromatics
Quarterly Results
Quarter-by-quarter operating performance
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 226.82 | 197.41 | 216.48 | 215.76 | 236.77 | 222.57 | 253.16 | 225.52 | 271.33 | 251.56 | 282.37 | 259.81 | 318.20 |
| YoY Sales growth | +2.75% | -1.01% | +10.82% | +10.26% | +4.39% | +12.75% | +16.94% | +4.52% | +14.60% | +13.03% | +11.54% | +15.20% | +17.27% |
| Expenses + | 215.81 | 183.30 | 195.60 | 193.65 | 208.15 | 200.02 | 233.89 | 207.46 | 254.09 | 238.34 | 262.91 | 240.01 | 292.93 |
| Operating Profit | 11.01 | 14.11 | 20.88 | 22.11 | 28.62 | 22.55 | 19.27 | 18.06 | 17.24 | 13.22 | 19.46 | 19.80 | 25.27 |
| OPM % | 4.85% | 7.15% | 9.65% | 10.25% | 12.09% | 10.13% | 7.61% | 8.01% | 6.35% | 5.26% | 6.89% | 7.62% | 7.94% |
| Other Income + | 2.81 | 2.16 | 1.74 | 1.69 | 2.10 | 0.09 | 0.24 | 0.27 | 3.00 | 2.06 | 4.27 | 1.00 | 0.50 |
| Interest | 5.46 | 6.87 | 3.43 | 4.06 | 6.34 | 6.36 | 8.62 | 8.07 | 9.72 | 9.30 | 8.66 | 7.81 | 8.64 |
| Depreciation | 4.94 | 4.96 | 5.08 | 4.89 | 5.16 | 6.40 | 7.23 | 7.70 | 7.81 | 7.82 | 7.74 | 7.72 | 7.80 |
| Profit before tax | 3.42 | 4.44 | 14.11 | 14.85 | 19.22 | 9.88 | 3.66 | 2.56 | 2.71 | -1.84 | 7.33 | 5.27 | 9.33 |
| Tax % | 29.24% | 41.22% | 28.28% | 26.13% | 23.10% | 27.73% | 60.93% | 80.47% | 73.06% | 4.35% | 45.70% | 52.37% | 37.94% |
| Net Profit + | 2.42 | 2.61 | 10.12 | 10.98 | 14.78 | 7.14 | 1.42 | 0.50 | 0.74 | -1.92 | 3.99 | 2.51 | 5.79 |
| EPS in Rs | 0.72 | 0.78 | 3.01 | 3.26 | 4.39 | 2.12 | 0.42 | 0.15 | 0.22 | -0.57 | 1.19 | 0.75 | 1.72 |
Financials of Oriental Aromatics
Profit & Loss
Annual income statement trend
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 458 | 506 | 755 | 760 | 709 | 873 | 854 | 842 | 928 | 1,031 | 1,112 |
| Sales growth | +11% | +49% | +1% | -7% | +23% | -2% | -1% | +10% | +11% | +14% | |
| Expenses + | 400 | 441 | 639 | 633 | 553 | 780 | 799 | 795 | 835 | 963 | 1,034 |
| Operating Profit | 57 | 65 | 116 | 127 | 156 | 93 | 54 | 47 | 94 | 68 | 78 |
| OPM % | 13% | 13% | 15% | 17% | 22% | 11% | 6% | 6% | 10% | 7% | 7% |
| Other Income + | 6 | -0 | -2 | 7 | 1 | 4 | 6 | 7 | 3 | 10 | 8 |
| Interest | 5 | 7 | 13 | 12 | 2 | 4 | 13 | 20 | 25 | 36 | 34 |
| Depreciation | 14 | 15 | 18 | 19 | 17 | 17 | 19 | 20 | 24 | 31 | 31 |
| Profit before tax | 44 | 43 | 83 | 103 | 137 | 76 | 27 | 14 | 48 | 11 | 20 |
| Tax % | 37% | 42% | 31% | 16% | 26% | 30% | 28% | 35% | 28% | 69% | |
| Net Profit + | 28 | 25 | 57 | 86 | 102 | 53 | 20 | 9 | 34 | 3 | 10 |
| EPS in Rs | 13.54 | 7.43 | 16.98 | 25.61 | 30.29 | 15.84 | 5.87 | 2.70 | 10.20 | 0.98 | 3.09 |
| Dividend Payout % | 3% | 7% | 6% | 10% | 8% | 9% | 9% | 18% | 5% | 51% |
Financials of Oriental Aromatics
Balance Sheet
Capital structure and asset base
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 8 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 311 | 329 | 375 | 447 | 540 | 588 | 608 | 616 | 646 | 648 | 654 |
| Borrowings + | 105 | 132 | 183 | 51 | 78 | 140 | 231 | 206 | 353 | 403 | 443 |
| Other Liabilities + | 69 | 103 | 98 | 93 | 110 | 120 | 130 | 157 | 129 | 127 | 186 |
| Total Liabilities | 490 | 573 | 673 | 608 | 745 | 865 | 986 | 995 | 1,145 | 1,194 | 1,301 |
| Fixed Assets + | 211 | 212 | 245 | 236 | 236 | 265 | 273 | 270 | 480 | 460 | 451 |
| CWIP | 15 | 40 | 1 | 2 | 13 | 25 | 53 | 173 | 5 | 5 | 8 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 264 | 321 | 428 | 370 | 496 | 574 | 661 | 551 | 660 | 730 | 841 |
| Total Assets | 490 | 573 | 673 | 608 | 745 | 865 | 986 | 995 | 1,145 | 1,194 | 1,301 |
Financials of Oriental Aromatics
Cash Flows
Operating, investing and financing cash movement
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 16 | -23 | 181 | 17 | -1 | -22 | 142 | -34 | 2 | |
| Cash from Investing Activity + | -31 | -12 | -10 | -35 | -59 | -46 | -99 | -86 | -12 | |
| Cash from Financing Activity + | 15 | 36 | -159 | 16 | 51 | 78 | -48 | 121 | 12 | |
| Net Cash Flow | 0 | 0 | 12 | -2 | -9 | 9 | -5 | -0 | 3 | |
| Free Cash Flow | -15 | -36 | 171 | -18 | -60 | -69 | 43 | -121 | -9 | |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 51% | -0% | 162% | 36% | 23% | -23% | 309% | -20% | 11% |
Financials of Oriental Aromatics
Ratios
Working capital efficiency and return ratios
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 80 | 97 | 77 | 73 | 97 | 81 | 81 | 78 | 74 | 89 |
| Inventory Days | 141 | 148 | 149 | 124 | 211 | 183 | 233 | 177 | 238 | 203 |
| Days Payable | 41 | 68 | 39 | 43 | 66 | 52 | 55 | 52 | 50 | 44 |
| Cash Conversion Cycle | 180 | 177 | 187 | 154 | 242 | 213 | 259 | 203 | 262 | 247 |
| Working Capital Days | 117 | 90 | 87 | 109 | 154 | 151 | 139 | 99 | 96 | 87 |
| ROCE % | 11% | 19% | 21% | 24% | 12% | 5% | 4% | 8% | 4% |
Guidance history
How Oriental Aromatics's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q2 FY27 call → | 10–20% | Flat | Planned | — | Rising |
| Q1 FY27 call → | 10–20% | Flat | Planned | — | — |
| Q4 FY26 call → | 0–10% | Up 0–2% | Planned | — | — |
| Q3 FY26 call → | 0–10% | Flat | Planned | — | Rising |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
44 out of 100 — Steady
Over the past year its share price has moved roughly in the middle of the stocks we track.
| Period | Share price change | Better than … of 1,928 stocks |
|---|---|---|
| Last 12 months | +40.4% | 80% |
| Last 6 months | +61.6% | 93% |
| Last 3 months | +30.1% | 93% |
The price is 51.8% below its all-time high of ₹1,021.35 (17 Sept 2021). Stocks more than 20% below their peak have their score halved, so 88 became 44.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,928 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Oriental Aromatics: 0.4 × 80 + 0.4 × 93 + 0.2 × 93 = 88, halved to 44 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 9 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Oriental Aromatics's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Unilex Colour &C (Q2 FY27)
685.02 lakhs (Consolidated) with a YoY increase of approximately 2.22% (Rs. Key results statement takeaways from Unilex Colour & Chemical Ltd's Q2 FY27 results
- Andhra Sugars (Q2 FY27)
3,276.52 lakhs (~5.5% increase) . Key results statement takeaways from Andhra Sugars Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- Shanti Inorganics (Q2 FY27)
54.02 crore (Rs. Key results statement takeaways from Shanti Inorganics Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- Prolife Industries (Q2 FY27)
Year-on-Year Change for PAT**: Specific YoY % change not provided; previous period PAT for the half year ended Sept 30, 2025 is not provided in the shared…
